03:29 PM EDT, 03/26/2026 (MT Newswires) -- Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index decreasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.2%.

The iShares Biotechnology ETF (IBB) was fractionally higher.

In corporate news, Boston Scientific's ( BSX ) CHAMPION-AF trial of its heart implant device to lower stroke risk is among the most anticipated study readouts this year, Oppenheimer said in a note Thursday. "To be clear, consensus view is that the trial will be successful, both technically & clinically," the report said. Boston Scientific ( BSX ) shares added 0.8%.